Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016, Article ID 3530752, 9 pages
http://dx.doi.org/10.1155/2016/3530752
Research Article

Delta Procalcitonin Is a Better Indicator of Infection Than Absolute Procalcitonin Values in Critically Ill Patients: A Prospective Observational Study

1Faculty of Medicine, Department of Anaesthesiology and Intensive Therapy, University of Szeged, 6 Semmelweis Street, Szeged 6725, Hungary
2Faculty of Medicine, Division of Infectious Diseases, First Department of Internal Medicine, University of Szeged, Szeged, Hungary
3Faculty of Medicine, Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary

Received 15 May 2016; Accepted 17 July 2016

Academic Editor: Roberta A. Diotti

Copyright © 2016 Domonkos Trásy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Critical Care Medicine, vol. 29, no. 7, pp. 1303–1310, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. M. M. Levy, A. Artigas, G. S. Phillips et al., “Outcomes of the surviving sepsis campaign in intensive care units in the USA and Europe: a prospective cohort study,” The Lancet Infectious Diseases, vol. 12, no. 12, pp. 919–924, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. C. Bone, C. J. Fisher Jr., T. P. Clemmer, G. J. Slotman, C. A. Metz, and R. A. Balk, “A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock,” The New England Journal of Medicine, vol. 317, no. 11, pp. 653–658, 1987. View at Publisher · View at Google Scholar · View at Scopus
  4. N. A. Lai and P. Kruger, “The predictive ability of a weighted systemic inflammatory response syndrome score for microbiologically confirmed infection in hospitalised patients with suspected sepsis,” Critical Care and Resuscitation, vol. 13, no. 3, pp. 146–150, 2011. View at Google Scholar · View at Scopus
  5. C. Galicier and H. Richet, “A prospective study of postoperative fever in a general surgery department,” Infection Control, vol. 6, no. 12, pp. 487–490, 1985. View at Google Scholar · View at Scopus
  6. A. Kumar, D. Roberts, K. E. Wood et al., “Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock,” Critical Care Medicine, vol. 34, no. 6, pp. 1589–1596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Carlet, V. Jarlier, S. Harbarth, A. Voss, H. Goossens, and D. Pittet, “Ready for a world without antibiotics? The Pensières antibiotic resistance call to action,” Antimicrobial Resistance and Infection Control, vol. 1, article 11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Pierrakos and J. L. Vincent, “Sepsis biomarkers: a review,” Critical Care, vol. 14, article R15, 2010. View at Google Scholar
  9. M. Meisner, Procalcitonin-Biochemistry and Clinical Diagnosis, Uni-med, Bremen, Germany, 1st edition, 2010.
  10. J. Garnacho-Montero, M. J. Huici-Moreno, A. Gutiérrez-Pizarraya et al., “Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis,” Critical Care, vol. 18, no. 3, article R116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Wacker, A. Prkno, F. M. Brunkhorst, and P. Schlattmann, “Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis,” The Lancet Infectious Diseases, vol. 13, no. 5, pp. 426–435, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Clec'h, F. Ferriere, P. Karoubi et al., “Diagnostic and prognostic value of procalcitonin in patients with septic shock,” Critical Care Medicine, vol. 32, no. 5, pp. 1166–1169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Mimoz, J. F. Benoist, A. R. Edouard, M. Assicot, C. Bohuon, and K. Samii, “Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome,” Intensive Care Medicine, vol. 24, no. 2, pp. 185–188, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Sponholz, Y. Sakr, K. Reinhart, and F. Brunkhorst, “Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature,” Critical Care, vol. 10, no. 5, article R145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Schuetz, B. Affolter, S. Hunziker et al., “Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: A Retrospective Cohort Study,” European Journal of Clinical Investigation, vol. 40, no. 4, pp. 376–381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Tsangaris, D. Plachouras, D. Kavatha et al., “Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay,” BMC Infectious Diseases, vol. 9, article 213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Trásy, K. Tánczos, M. Németh et al., “Early procalcitonin kinetics and appropriateness of empirical antimicrobial therapy in critically ill patients,” Journal of Critical Care, vol. 34, pp. 50–55, 2016. View at Publisher · View at Google Scholar
  18. “American college of chest Physicians/Society of critical care medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Critical Care Medicine, vol. 20, pp. 820–864, 1992.
  19. T. Calandra and J. Cohen, “International Sepsis Forum Definition of Infection in the ICU Consensus Conference. The international sepsis forum consensus conference on definitions of infection in the intensive care unit,” Critical Care Medicine, vol. 33, pp. 1538–1548, 2005. View at Google Scholar
  20. R. P. Dellinger, M. M. Levy, A. Rhodes et al., “Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012,” Critical Care Medicine, vol. 41, no. 2, pp. 580–637, 2013. View at Publisher · View at Google Scholar
  21. C.-E. Luyt, N. Bréchot, J.-L. Trouillet, and J. Chastre, “Antibiotic stewardship in the intensive care unit,” Critical Care, vol. 18, no. 5, article 480, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Manek, V. Williams, S. Callery, and N. Daneman, “Reducing the risk of severe complications among patients with Clostridium difficile infection,” Canadian Journal of Gastroenterology, vol. 25, no. 7, pp. 368–372, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Bozkurt, S. Kaya, R. Tekin et al., “Analysis of antimicrobial consumption and cost in a teaching hospital,” Journal of Infection and Public Health, vol. 7, no. 2, pp. 161–169, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. M. M. Levy, M. P. Fink, J. C. Marshall et al., “2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference,” Intensive Care Medicine, vol. 29, no. 4, pp. 530–538, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Shehabi, M. Sterba, P. M. Garrett et al., “Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis: a randomized controlled trial,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 10, pp. 1102–1110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. D. E. Fry, “Sepsis syndrome,” American Surgeon, vol. 66, no. 2, pp. 126–132, 2000. View at Google Scholar · View at Scopus
  27. B. Coburn, A. M. Morris, G. Tomlinson, and A. S. Detsky, “Does this adult patient with suspected bacteremia require blood cultures?” The Journal of the American Medical Association, vol. 308, no. 5, pp. 502–511, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. Q. Zhang, M. Raoof, Y. Chen et al., “Circulating mitochondrial DAMPs cause inflammatory responses to injury,” Nature, vol. 464, no. 7285, pp. 104–107, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Uzzan, R. Cohen, P. Nicolas, M. Cucherat, and G.-Y. Perret, “Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis,” Critical Care Medicine, vol. 34, no. 7, pp. 1996–2003, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Layios, B. Lambermont, J.-L. Canivet et al., “Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients,” Critical Care Medicine, vol. 40, no. 8, pp. 2304–2309, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. J. U. Jensen, L. Hein, B. Lundgren et al., “Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial,” Critical Care Medicine, vol. 39, no. 9, pp. 2048–2058, 2011. View at Publisher · View at Google Scholar · View at Scopus